Controlled studies on the effectiveness of inpatient psychotherapy with patients with personality disorders (PD) are rare. This study aims to compare 3-month short-term inpatient psychotherapy based on transactional analysis (STIP-TA) with other psychotherapies (OP) up to 36-month follow-up. PD patients treated with STIP-TA were matched with OP patients using the propensity score. The primary outcome measure was general psychiatric symptomatology; secondary outcomes were psychosocial functioning and quality of life. In 67 pairs of patients, both STIP-TA and OP showed large symptomatic and functional improvements. However, STIP-TA patients showed more symptomatic improvement at all time points compared to OP patients. At 36 months, 68% of STIP-TA patients were symptomatically recovered compared to 48% of OP patients. STIP-TA outperformed OP in terms of improvements in general psychiatric symptomatology and quality of life. Superiority of STIP-TA was most pronounced at 12-month follow-up, but remained intact over the course of the 3-year follow-up.
There is now compelling evidence to support the hypothesis that personality disorders (PDs) are treatable and changeable (e.g., Arnevik et al., 2010; Binks et al., 2006; Dixon-Gordon, Turner, & Chapman, 2011; Gabbard, 2000; Leichsenring & Leibing, 2003; Perry, Banon, & Ianni, 1999; Stoffers et al., 2012) .Based on the evidence, various systematic literature reviews and clinical guidelines conclude that psychotherapy is the treatment of first choice (e.g., Bartak, Soeteman, Verheul, & Busschbach, 2007; Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ, 2008 ; National Institute for Health and Clinical Excellence, 2009a, 2009b) . Although most studies concern well-known treatments for borderline personality disorder (BPD), such as schema-focused therapy (SFT), transference-focused psychotherapy (TFP), dialectical behavior therapy (DBT), and mentalization-based treatment (MBT) (e.g., Dixon-Gordon et al., 2011; Gabbard, 2000) , a growing number of studies document psychotherapy's effectiveness with other PDs as well. In the past 10 years, several reviews were done on the effectiveness of psychotherapeutic treatments with general PD patients. Positive results were reported for time-limited psychodynamic psychotherapy and cognitive-behavioral therapy (Leichsenring & Leibing, 2003; Matusiewicz, Hopwood, Banducci, & Lejuez, 2010; Town, Abbass, & Hardy, 2011; Verheul & Herbrink, 2007) , whereas rather limited and conflicting evidence was reported concerning long-term psychoanalytic psychotherapy (Smit et al., 2012) .
Remarkably, the treatment literature on PD typically considers long-term treatments in an outpatient setting. An interesting and viable alternative might be short-term inpatient psychotherapy (STIP). For example, Bartak et al. (2010) and Soeteman et al. (2011) have recently shown superior effectiveness and efficiency of STIP (with a maximum duration of 6 months) as compared to other treatment modalities in patients with a Cluster C PD. In that particular study, STIP included a variety of durations (e.g., both 3-month and 6-month psychotherapy) and theoretical orientations (e.g., cognitivebehavioral and psychodynamic treatment). The current study focuses on the effectiveness of the shortest, 3-month variant, that is, STIP based on transactional analysis (STIP-TA). Thunnissen et al. (2008) reported on treatment outcome of STIP-TA in a naturalistic cohort study and found a 2.0 effect size 2 years after the start of the treatment, and a recent review of studies on TA in psychotherapy found a positive effect of TA in more than 80% of the studies reviewed (Ohlsson, 2010) . This study will compare the effectiveness of STIP-TA to other specialized psychotherapies (OPs) in PD patients in a nonrandomized, but nevertheless rigorously controlled trial.
METHODS

STUDY POPULATION AND DESIGN
Patients were recruited from March 2003 to March 2006 from a consecutive series of admissions to six mental health care institutes in the Nether-lands offering specialized psychotherapy for adult patients with PD. In this period of time, 1,379 patients completed the intake procedure. Of these, 837 had a DSM-IV-TR PD diagnosis (American Psychiatric Association, 2000) , provided informed consent, and were enrolled in the Study on Cost-Effectiveness of Personality Disorder Treatment (SCEPTRE), a large multicenter project in the Netherlands focusing on the effectiveness and cost-effectiveness of psychotherapeutic treatments in PD patients (Bartak et al., 2010) . After informed consent, 38 patients dropped out prematurely. This left 764 patients, of which 76 received STIP-TA at De Viersprong, Netherlands Institute for Personality Disorders, and 688 patients received OPs. Five STIP-TA patients and 100 OP patients were lost to follow-up. It was not possible to find a good match for four STIP-TA patients; therefore, 67 STIP-TA patients were matched to 67 OP patients 1-to-1 by the logit of the propensity score, which left 134 patients for this trial (see Figure 1 ).
HANDLING DATA
All outcome measures were assessed at baseline and several follow-up points. Various follow-up points had to be used for logistic reasons: Three treatment centers had their assessments at baseline, at the end of the treatment, at 6 and 12 months after the end of treatment, and at 36 and 60 months after baseline, whereas three other centers had their assessments at baseline and at 12, 24, 36, and 60 months after baseline. Ninetyfive percent of the STIP-TA patients had three or more follow-up measurements, compared to 88% of the matched OP patients.
STATISTICAL ANALYSES
The matching of patients was done by matching each patient 1-to-1 on the logit of the propensity score (Rosenbaum & Rubin, 1985) . The propensity score (PS) and the matching are explained here. The PS is defined as the conditional probability of assignment to one of two treatment groups given a set of observed pretreatment variables (Bartak et al., 2009; Rosenbaum & Rubin, 1983) . To estimate the PS, we fitted one logistic regression model with group membership (STIP-TA or OP) as outcome. To create two similar samples at baseline, relevant confounders related to the outcome variable were used as independent variables (Brookhart et al., 2006) . Fifty-four sociodemographic and clinical variables were selected as potential confounders based on clinical knowledge and a literature review. Of these, 27 variables had a significant influence on the outcome and were used in the estimation of the PS. Sociodemographic variables (e.g., age, sex, level of education) and clinical variables (e.g., motivation, baseline scores of the outcome measures, SIPP-118 scales, PD diagnoses) were included (a full list of these variables is provided in the Appendix). Additionally, indirect and direct medical costs in a 12-month period before baseline were added as potential confounders in order to create a sample that can be used for future cost-effectiveness analyses. Because the logit of the PS is more likely to be normally distributed than the propensity score, matching was done on the logit of the PS. The logit is the logarithm of the PS divided by one minus the PS. To receive optimal balance between the treatment groups, a caliper distance of .2 of the standard deviation (SD) of the logit of the PS was used (Austin, 2011) .
The matching was done by first ordering subjects of the STIP-TA group randomly. The control subject with the smallest distance of the PS logit with the STIP-TA subject and whose PS logit fell within the caliper width was identified as a match. This pair was then removed from the pool and a match was sought for the next STIP-TA subject. STIP-TA subjects for whom no match could be found with a PS logit within the caliper were also removed.
Multilevel models were used for the analysis of outcomes over time. We used multilevel modeling to deal with (a) the dependency of the repeated measures within the same subject in time, (b) the dependency of patients within a pair, and (c) the longitudinal data with observations unequally spaced in time. The levels were (a) time within patients, (b) patients within pairs and (c) pairs. To estimate the treatment effects at 12, 24, and 36 months after baseline, we used random effects for pairs, patients within pairs, and time within patients. We used a random intercept model with time as Level I and pair number as Level II and a second model with a random intercept and random slope with time as Level I and patient number as Level II. In addition to a linear time effect, we postulated knots (or splines) every 6 months, which allowed the estimated course of the dependant variable to bend at these time points. Nonsignificant knots (p < .05) were deleted from the models until a parsimonious model was reached that did not differ significantly from the original saturated model. This resulted in a final best fitting model with the change scores (from baseline) observed during follow-up for each of the outcome measures as dependent variables and the following independent variables: group membership, time, interaction between group membership and time, the deviation of the overall baseline score (in order to take the baseline scores into account), a linear spline (knot point at 18 months), and interaction of the spline with the treatment group. Subsequently, we calculated withingroup effect sizes (Cohen's d ) to describe change from baseline to 12, 24, and 36 months in both groups (Cohen, 1988) . We used the estimated pooled SDs by combining the baseline SD with the follow-up SDs from the models.
Outcome analyses are based on the intention-to-treat (ITT) principle. All patients who received a "minimal effective dosage" (defined as at least two sessions of outpatient psychotherapy or at least two treatment days of day hospital or inpatient psychotherapy) were followed and included in the analyses. The analyses were performed using IBM SPSS 20.0 (IBM Corporation, USA) for data preparation and SAS 9.2 (SAS Institute Inc., USA) for multilevel modeling. Differences of p < .05 were considered statistically significant.
ASSESSMENTS
BASELINE MEASURES
An extensive standard assessment battery of instruments was administered to the patients before treatment assignment.
Classification of PD. PDs were classified using the Dutch version of the Structured Interview for DSM-IV Personality (SIDP-IV) (De Jong, Derks, van Oel, & Rinne, 1996; Pfohl, Blum, & Zimmerman, 1997) . This interview covers the 11 formal DSM-IV-TR Axis II diagnoses, including PD Not Otherwise Specified (PDNOS). The PDNOS diagnosis applied to either an appendix diagnosis (i.e., depressive, passive-aggressive PD, or self-defeating PD) or a mixed PD (meeting 10 or more diagnostic criteria of various PDs). Interviewers were master-level psychologists who were trained thoroughly and who received monthly booster sessions to avoid deviation from the interviewer guidelines. Percentage of agreement between observer-raters ranged from 84% (avoidant PD) to 100% (schizoid) (median 95%). To estimate the intraclass correlation coefficients [ICC (2, 1)] for the sum of DSM-IV PD traits present (i.e., scores 2 or 3), 25 videotaped interviews were rated by three (out of 25) random observers, which resulted in 75 observations. The intraclass correlation coefficients [ICC (2, 1)] ranged from 0.31 (schizotypal PD) through 0.88 (depressive PD) (median 0.66).
Self-Report. Besides the three outcome measures GSI, OQ-45, and EQ-5D (discussed below), three additional self-report instruments to measure patient characteristics were included in the assessment battery at baseline and were used as potential confounders for the PS. First, the Dutch version of the Dimensional Assessment of Personality Pathology-Basic Questionnaire (DAPP-BQ) measures type and degree of personality pathology (Livesley, 2002; van Kampen, 2002) . We used patients' scores on this questionnaire on the four higher-order factors: emotional dysregulation, dissocial behavior, inhibition, and compulsivity. Second, to measure patients' motivation for treatment, the two scales of the Motivation for Treatment Questionnaire (MTQ-8) were used: need for help and readiness to change (van Beek & Verheul, 2008) . Third, the Severity Indices of Personality Problems-118 (SIPP-118) is a self-report questionnaire aimed to measure five core domains of personality pathology: self control, identity integration, responsibility, relational functioning, and social concordance .
MAIN OUTCOME MEASURES
The primary outcome measure was general psychiatric symptomatology, as measured by the Global Severity Index (GSI) of the Dutch version of the Brief Symptom Inventory (BSI). The BSI is a brief self-report questionnaire that covers nine symptom dimensions and is developed from the Symptom Checklist 90-Revised (SCL-90-R) (Arrindell & Ettema, 2003; Derogatis, 1983) . The GSI is calculated as the mean score of the 53 items of the BSI, ranging from 0 to 4 (De Beurs & Zitman, 2006; Derogatis, 1992; Derogatis & Melisaratos, 1983) .
As secondary outcomes, psychosocial functioning was measured using two subscales of the Outcome Questionnaire-45 (OQ-45), that is, Interpersonal Relations and Social Role (Lambert et al., 2004) , and health-related quality of life was measured using the EQ-5D (EuroQolGroup, 1995) . A study in the Netherlands measured and valuated the EQ-5D, resulting in the Dutch EQ-5D value set, which is used to calculate utilities for EQ-5D health states (Lamers, Stalmeier, McDonnell, Krabbe, & van Busschbach, 2005) .
To evaluate clinically significant change at 36 months after baseline in terms of the GSI and the OQ-45, we followed the criteria of Jacobson and Truax (1991) . The cutoff and reliable change index of the manual of the BSI (Derogatis, 2011) and of the article on the validation of the OQ-45 in a Dutch population (De Jong et al., 2007) , respectively, were used. Differences between treatment groups were analyzed using McNemar's test.
INTERVENTIONS
STIP-TA
Transactional analysis (TA) is a theory of personality development, intrapsychic functioning, and interpersonal behavior developed by Eric Berne in the 1950s (Berne, 1996) . It is based on psychoanalytical ideas and integrates elements of ego psychology, object relations theory, and learning theory (Berne, 1996) . The aim of TA is to think, feel, and act more adaptively by changing old and dysfunctional patterns of behavior. Although TA does not explicitly address work on mentalizing and metacognition, these concepts are extensively addressed in TA and described in Hawkes (2011) .
STIP-TA incorporated the ideas of transactional analysis in a very short (13 weeks) inpatient psychotherapy. It was specifically designed for and tailored to the needs of patients with various PDs, particularly Cluster C PD and PDNOS. The program typically includes patients with childhood traumatic experiences, such as severe illness, disability or death (sometimes by suicide) of a parent, emotional or physical neglect, and sexual or physical abuse. The treatment is guided by an individual treatment contract. In this contract, patients state how they want to change their patterns of thinking, feeling, and behavior. The TA program helps them understand how they function interpersonally and how they can start to see connections between their external and internal worlds and the roots of their patterns, originating in their childhood experiences.
STIP-TA includes the following seven characteristics: One shared vision that is carried out by the staff; one shared language; shared responsibility of patients and staff; working with contracts on a focal spectrum of problems; structure in time, place, and person; continuous evaluation of progress; and active and well-trained therapists (Delimon, 1999) . STIP-TA includes group psychotherapy, psychomotor and art therapy, sociotherapy, and milieu therapy. Nonverbal therapies are included because they are better entrances for many patients to explore their dysfunctional patterns compared to verbal therapies. As therapists (including the psychotherapist, psychosocial nurses, psychiatrist, and nonverbal therapist) work very closely together and share their experiences in working with the patient group two times a day, patients are followed carefully in their treatment process and progress (Delimon, 1999; Thunnissen, 2007) .
OTHER PSYCHOTHERAPIES
The specialized psychotherapies consisted of treatments varying widely in terms of setting (i.e., outpatient, day hospital, and inpatient), duration (i.e., ranging from 3-month to 36-month programs), and theoretical orientation (e.g., cognitive-behavioral or psychodynamic). The matched OP group consisted of six patients (9%) following short-term and 18 patients (27%) following long-term outpatient therapy (i.e., individual or group psychotherapy sessions, up to two sessions per week); seven patients (10%) following short-term and 11 patients (16%) following long-term day hospital therapy (i.e., at least one morning/afternoon per week, various forms of psychotherapeutic and psychosocial treatments, but sleeping at home); and nine patients (13%) following short-term and 16 patients (24%) following long-term inpatient therapy (i.e., staying at the hospital up to 5 days a week, including various forms of psychotherapeutic and psychosocial treatments). Day hospital and inpatient programs typically consisted of group psychotherapy as a core element, mostly in combination with one or more nonverbal or expressive group therapies (such as psychomotor and art therapy), individual psychotherapy, sociotherapy, milieu therapy, community meetings, and/or pharmacological treatment. Twenty-two percent of treatments had a cognitive-behavioral orientation, 30% had a psychodynamic orientation, 43% had an integrative orientation, and the remaining 5% had an unspecified orientation. The psychotherapists were all licensed psychiatrists or psychologists. All treatments under study were tailored to patients with personality pathology and can be considered highly representative of specialist mental health care in the Netherlands.
RESULTS
SAMPLE
The sociodemographic and clinical characteristics of STIP-TA and OP patients are displayed in Table 1 . As expected, differences between the two groups were not significant (t tests and χ² tests). The mean age of patients in STIP-TA was 39.4 years and in OP was 39.3 years. Thirty-three percent of STIP-TA patients and 27% of OP patients were male. Forty-nine percent of STIP-TA patients and OP patients were living together with a partner. Fifty-eight percent of STIP-TA patients and 57% of OP patients worked or were studying. Most patients (91% STIP-TA, 88% OP) were diagnosed with a Cluster C PD (49% STIP-TA, 39% OP) and/or a PDNOS (42% STIP-TA, 49% OP). Most of the sample had a history of outpatient treatment. Figure 2 displays the distribution of the estimated probabilities of assignment to STIP-TA (propensity scores) before and after matching. After matching, the STIP-TA group and the OP group were virtually equal with respect to the distribution of the propensity scores, with STIP-TA patients having a propensity score of .259 (SD = .18) and matched controls of .260 (SD = .18, t(66) = .26, p = .797).
TREATMENT ADHERENCE
Because the SCEPTRE study initially focused on treatment dosage only, intended and realized treatments were described in terms of setting (outpatient, day hospital, or inpatient psychotherapy) and duration of the treatments (short-or long-term). At the end of the treatment, 100% of the STIP-TA patients had completed the intended treatment dosage, compared to 85% of the OP patients, a significant difference (χ 2 = 10.81, df = 1, p = .001). Of the patients who changed treatment dosage, the deviation of the intended dosage was mainly due to the duration of treatment: 50% received a shorter treatment, while the remaining 50% received a longer treatment. One OP patient (2%) also changed the treatment setting. TREATMENT OUTCOME At all time points (12, 24, and 36 months), both groups showed symptomatic improvements and large effect sizes (Cohen, 1992) . Nevertheless, the STIP-TA group outperformed the OP group at all time points, especially at 12 months after the start of treatment (b = .35, p < .001; see Table 2 ). Effect sizes at 12-month follow-up were 2.02 for STIP-TA and 1.18 for OP. At 36 months, STIP-TA still outperformed OP (b = .21, p = .0082; see Table  2 ), with effect sizes of 1.93 for STIP-TA and 1.39 for OP. Figure 3 shows the course of general psychiatric symptomatology over 36 months.
FIGURE 2. Distribution of estimated probabilities of assignment to STIP-TA treatment (propensity scores) before and after matching. At 36 months after baseline, 44 pairs of patients (66%) had a 36-month follow-up measurement and were compared in terms of clinically significant change. Ninety percent of the STIP-TA patients and 71% of the OP patients showed a reliable change (p = .03), and 0% of STIP-TA patients and 4% of OP patients demonstrated clinical deterioration in terms of psychiatric symptomatology (McNemar's test can be carried out only for a p × p table, where p must be greater than 1.). Sixty-eight percent of STIP-TA patients and 48% of OP patients moved from a dysfunctional range to a normative range (p = .08). All patients who moved from a dysfunctional range to a normative range also demonstrated reliable change.
Two additional sensitivity analyses were done to further examine the data. First, a sensitivity analysis was done on the severity of PD pathology. Patients scoring 15 or fewer PD criteria (median number of traits) were considered less severe, while patients scoring more than 15 traits were considered more severe. Up to 3 years, no significant differences were found on the GSI between more or less severe patients in STIP-TA or OP on either follow-up point. Differences in recovery at 36-month follow-up between more or less severe patients were also negligible. Second, separate analyses were done to compare dosages in the STIP-TA group with different dosages in the OP group. These analyses indicated that part of the superior effect of STIP-TA could be attributed to the lower effectiveness of inpatient treatments in the OP sample.
With respect to the secondary outcomes, that is, psychosocial function- ing (OQ-45) and health-related quality of life (EQ-5D), we found medium to large improvements from baseline to 36 months in both groups as well. Regarding psychosocial functioning, STIP-TA patients showed larger effect sizes than OP patients on all scales at all time points, except for one (i.e., OQ-45 Interpersonal Relations, 24 months; STIP-TA: M = 15.67, SD = 4.37; OP: M = 15.10, SD = 4.68). However, differences between the groups were nonsignificant. Regarding the OQ-45 Interpersonal Relations subscale, at 36 months after baseline, 47 pairs of patients (70%) had a 36-month follow-up measurement. Fifty-one percent of the STIP-TA patients and 34% of the OP patients showed a reliable change (p = .17); 2% of each group demonstrated clinical deterioration (p = 1.00). Thirty-eight percent of STIP-TA patients and 30% of OP patients moved from a dysfunctional range to a normative range (p = .56). Of these, 32% and 21%, respectively, moved from a dysfunctional range to a normative range and demonstrated reliable change (p = .38). With regard to the OQ-45 Social Role subscale, 46 pairs of patients (69%) had a 36-month follow-up measurement. We found that 50% of STIP-TA patients and 24% of OP patients showed a reliable change (p = .01). None of the STIP-TA patients and 2% of the OP patients demonstrated clinical deterioration. Fifty percent of STIP-TA patients and 37% of OP patients moved from a dysfunctional range to a normative range (p = .26), and of these, 30% of STIP-TA patients and 20% of OP patients moved from a dysfunctional range to a normative range and demonstrated reliable change (p = .30).
Regarding quality of life, significant larger effect sizes were found for STIP-TA patients compared to OP patients at 12 and 24 months, but not at 36 months (see Table 2 ). The STIP-TA group approached the level of quality of life observed in the general population (which was defined as a value of 0.88) at 12 months, with a small decline at 24 and 36 months, while the OP group lagged behind (Busschbach, Wolffenbuttel, Annemans, Meerding, & Koltowska-Haggstrom, 2011) .
Significant differences between patients who completed their intended treatment dosage and patients who did not were found on the two outcome measures assessing psychosocial functioning at 12-month follow-up (OQ-45 Social Role: b = 3.46, p = .03; OQ-45 Interpersonal Relations: b = 5.54, p = .02). Patients who completed the intended treatment dosage showed significantly better psychosocial functioning than patients who did not.
DISCUSSION
The current study showed that time-limited, short-term inpatient psychotherapy based on transactional analysis outperformed a variety of other specialized psychotherapies in terms of improvements in general psychiatric symptomatology and quality of life. The superiority of STIP-TA was most pronounced at 12-month follow-up, but remained intact over the course of the entire 3-year follow-up period. Sensitivity analyses showed that our findings were (relatively) independent of baseline severity and dosage in the control condition. These results support and extend findings of previous studies of STIP-TA (Thunnissen et al., 2008) and STIP in Cluster C patients (Bartak et al., 2010) , thereby strengthening the conclusion that STIP-TA is a very promising treatment program for patients with Cluster C PD or PDNOS.
In terms of general psychiatric symptomatology, we found effect sizes of 1.87 to 2.02 for STIP-TA patients and 1.18 to 1.39 for OP patients across 3 years of follow-up. Our assessment of clinically meaningful change at 36 months after baseline showed a small but insignificant advantage in favor of STIP-TA, with 68% of STIP-TA patients and 48% of OP patients being symptomatically recovered. Other studies on reliable change or recovery rates of PD patients showed varying results. In Cluster C, 10%-54% of patients showed reliable change or recovery (Muran, Safran, Samstag, & Winston, 2005; Svartberg, Stiles, & Seltzer, 2004) . In Cluster B, response or reliable change rates of 38%-80% were found (Chiesa & Fonagy, 2003; Kröger, Harbeck, Armbrust, & Kliem, 2013; McMain, Guimond, Streiner, Cardish, & Links, 2012) . Thus, results of the current study showed higher recovery rates than other published effect studies of Cluster C patients, and were within the range of rates found in studies of Cluster B patients. It is difficult to interpret these differences, however, because they might be accounted for by a variety of reasons, such as differences in (a) effectiveness of treatments, (b) the follow-up period, (c) definition of response or recovery, and (d) patient characteristics, such as the severity of personality pathology.
Concerning the secondary outcome measures, we found that STIP-TA patients approached the level of quality of life observed in the general population, while the OP patients lagged behind. Significant differences in quality of life between STIP-TA and OP patients vanished at the long-term follow-up. Less pronounced results were found concerning psychosocial functioning. About one third of STIP-TA patients and one fifth of OP patients could be considered recovered after 36 months. The limited impact of treatment on social functioning found in the current study is consistent with other studies showing that the treatment of PD has limited impact on social functioning (e.g., Arnevik et al., 2010; Chiesa & Fonagy, 2003; McMain et al., 2012; Skodol et al., 2005) . Because these studies primarily focused on long-term treatments, and about two thirds of the OP treatments in the current study were considered long-term, the length of treatment may not be the main reason why we found lower effects in this area. Instead, the results support the hypothesis that maladaptive interpersonal patterns are core features of PDs and improve more slowly than psychiatric symptomatology. More research is necessary to study which variables need to be targeted in psychotherapy to receive better results and to be able to tailor treatments to the needs of individual PD patients (Dimaggio, Nicolò, Semerari, & Carcione, 2013) . Chiesa and Fonagy (2003) suggested the following reasons for the slow pace of improvement: (a) social adjustment refers to a more complex dimension that is more difficult to change, (b) social adjustment could be "intrinsically linked to the concept of PD, with the notion of durability and persistence" (p. 359), (c) parts of social adjustment could be heavily dependent on external factors such as unemployment due to economic circumstances, and (d) instruments used could be unsuitable in PD patients.
METHODOLOGICAL CONSIDERATIONS
Several methodological considerations are worth mentioning. First, this study is not a randomized controlled trial (RCT), but a matched-control study that merely mimics an RCT. However, this can be considered a limitation as well as a strength. RCTs are generally criticized for their limited external validity because treatments take place under strictly controlled or experimental circumstances, the only patients studied are those who agree to randomization, and exclusion criteria are typically stringent (e.g., Hodgson, Bushe, & Hunter, 2007) . In contrast, the treatments in the current study can be considered highly representative of specialist mental health care in the Netherlands (Bartak et al., 2010) . Furthermore, this limitation is somewhat mitigated by our rigorous matching procedure, which ensures the similarity of the patient groups and partly rules out the possibility of selection bias. Nevertheless, because we matched patients on the PS, which was computed using predetermined and observable variables, it is possible that other patient differences that were either not predetermined or not observable affected assignment to treatment and confounded the observed differences in treatment effectiveness (Austin, 2008) . The likelihood of confounding, however, is mitigated by the fact that we tested a large number of possible confounding variables. Second, we used only self-report instruments as outcome measures. We do not have information whether the treatments were also able to change the PD diagnosis of patients or whether therapists considered the change sufficient.
Third, information about the treatment fidelity and adherence was not collected. However, it is reasonable to assume that treatments delivered in specialized treatment centers by experienced psychotherapists are of relatively high quality. Perhaps more importantly, several ingredients of STIP-TA are specifically designed to maintain treatment integrity (e.g., staff training, ongoing supervision, and multidisciplinary meetings twice a day).
Fourth, the interpretation of the results is limited by the variation of treatment modalities in the OP condition. This study therefore does not clarify the observed superiority of STIP-TA. For example, it is not at all clear from this study whether the observed superiority of STIP-TA is best accounted for by either setting (inpatient), duration (short-term), psychotherapeutic orientation (transactional analysis), a combination thereof, or even another factor such as the consistent application of the theoretical framework, which has been hypothesized to be one of the general ingredients of effec-tive treatments (Bateman & Fonagy, 2000) . Because inpatient or residential psychotherapeutic treatments in PD patients are not part of treatment as usual in other countries, and because part of the superior effect of STIP-TA could be attributed to the lower effectiveness of inpatient treatments in the OP sample, the generalizability of the results to other countries is limited.
IMPLICATIONS AND FUTURE DIRECTIONS
The results of our study are consistent with several studies showing that psychological treatments tailored to PD patients are generally very effective and effect sizes of STIP-TA are even larger compared to those typically observed in previous studies (e.g., Arnevik et al., 2010; Leichsenring & Leibing, 2003) . Because STIP-TA patients are hospitalized for 13 weeks, it is also a relatively expensive treatment, which may be an obstacle to reimbursement for this treatment in some countries. Nevertheless, Soeteman et al. (2011) showed that in Cluster C PDs, STIP seemed to be most costeffective compared to other treatment modalities. A cost-effectiveness study comparing STIP-TA to OP adds more evidence to the knowledge of effective and cost-effective treatments in PD patients and will be conducted in the future.
Recent studies point to the need of a refinement of existing treatments for PD. Until now, the treatments studied have focused mostly on BPD, on distinct areas of pathology, and on comparisons of different psychotherapies. There is a paucity of research to guide treatment and enhance outcome in PD patients (Critchfield & Benjamin, 2006) . Because most research has shown that differences in effectiveness of active treatments in PD are negligible ("equivalence effect") (Budge et al., 2013; Dimaggio, 2014) , a recent issue of the Journal of Personality Disorders stressed the need for the development of comprehensive and integrated treatments for PD patients (Dimaggio & Livesley, 2012) . Instead of conducting further comparisons of different treatments, research should be concentrated on the active ingredients of treatments (Clarkin, 2012) . Recent studies point to generic effective principles of change in psychotherapeutic treatments of PD. Three factors that seem to be potentially related to outcome are participant characteristics, therapeutic relationship variables, and technical factors (Castonguay & Beutler, 2006) . Elements such as the therapeutic alliance, the ability of the therapist to repair ruptures in the alliance, and cohesion in group therapy might be important factors in the therapeutic relationship and therefore important factors in the effectiveness of treatment (Castonguay & Beutler, 2006; Norcross, 2002; Tufekcioglu, Muran, Safran, & Winston, 2013) . Because STIP-TA is known for its low dropout rates and because ruptures in the alliance were a main issue of the therapy, these may be factors that could explain part of its high effectiveness. The previously mentioned articles highlight the need for research on the principles of change and on the efficacious ingredients of effective treatments for PD patients, including STIP-TA. STIP-TA is known as a high-pressure and potentially destabilizing treatment and as such will not be the first choice of treatment for severely disturbed patients. With these PD patients, this treatment may be too destabilizing, because not all patients seem to be able to withstand the "pressure cooker" of this kind of treatment (Chiesa, Fonagy, & Gordon, 2009 ), which could result in more dropouts, suicidality, or psychotic decompensation. For example, Gullestad, Johansen, Hoglend, Karterud, and Wilberg (2013) have found that day hospital treatments and its group therapy format were too demanding for patients with low reflective functioning (i.e., a low level of mentalizing), which resulted in worse treatment effects compared to those from individual therapy. Cluster C PD patients might be able to handle the pressure and intensity of such treatment when it is provided in a safe and holding environment. Because these patients often show rigid patterns of behavior motivated by anxiety, an intensive, inpatient treatment is preeminently suited for them. Furthermore, a short hospitalization has less impact on daily life and reduces the risk of iatrogenic effects, which can be associated with long-term inpatient treatments. In addition, it is of practical relevance to study whether more seriously disordered patients can profit from this intensive kind of treatment and whether it is possible to expand the target population to (relatively mild) Cluster A and B PD patients. In a study on the effectiveness of aftercare following STIP-TA, almost 30% of the patients were diagnosed with either a Cluster A or B PD (Thunnissen et al., 2008) . A secondary analysis of these patient groups showed that patients with a Cluster A or B PD showed a different pattern of improvement over time (Thunnissen, 2007) . At 24-month follow-up, however, patients showed similar symptom levels and large effect sizes. This might indicate that STIP-TA can also be effective for these patient groups. It is therefore clinically relevant to further investigate the safety and applicability of STIP-TA in Cluster A and B PD.
This study showed that STIP-TA is a very promising and effective treatment option in mainly Cluster C PD and PDNOS patients. To make this treatment available to more patients, additional research on the effectiveness and cost-effectiveness of this treatment is recommended. The extent to which difficulties in the social roles of worker, homemaker, or student are present EQ-5D
APPENDIX. Potential Confounders Tested for Propensity
Health-related quality of life SIPP Self-Control
The capacity to tolerate, use, and control one's own emotions and impulses SIPP Identity Integration
Coherence of identity; the ability to see oneself and one's own life as stable, integrated, and purposive SIPP Relational Functioning
The capacity to genuinely care about others as well as feeling cared about by them, to be able to communicate personal experiences, and to hear and engage with the experiences of others often but not necessarily in the context of a long-term, intimate relationship SIPP Social Concordance
The ability to value someone's identity, withhold aggressive impulses towards others, and to work together with others SIPP Responsibility
The capacity to set realistic goals and to achieve these goals in line with the expectations you have generated in others SIDP-IV Dimensional score Cluster C PD 
